☆ 4.8 Article

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

JOURNAL OF HEPATOLOGY (2016)

Get Full Text
Add to Collection

Journal

JOURNAL OF HEPATOLOGY
Volume 64, Issue 6, Pages 1388-1402

Publisher

ELSEVIER
DOI: 10.1016/j.jhep.2015.11.004

Keywords

-

Categories

Gastroenterology & Hepatology

Funding

  1. Abbott Laboratories
  2. Boehringer Ingelheim
  3. Novartis Pharma
  4. Sanofi-Aventis Germany
  5. Eli Lilly
  6. Novo Nordisk
  7. Amylin-BMS-AstraZeneca
  8. Sanofi-Aventis
  9. AstraZeneca

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.